Announced first patient dosed in the Phase 2b placebo-controlled portion of the EP-104GI RESOLVE trial with topline data expected in H2 2026Announced positive data from Phase 1b/2a RESOLVE supporting the potential of EP-104GI to improve the standard of care for patients with Eosinophilic Esophagitis (“EoE”)Additional data from cohorts 5–8 from Phase 1b/2a available in October 2025 VICTORIA, British Columbia, Aug. 12, 2025 (GLOBE NEWSWIRE) -- Eupraxia Pharmaceuticals Inc. (“Eupraxia” or the “Company”) (NASDA ...

HOUSTON, Aug. 12, 2025 (GLOBE NEWSWIRE) -- Amplify Energy Corp. (“Amplify” or the “Company”) (NYSE: AMPY) announced today that the Company will be participating in the 30th Annual EnerCom Denver – The Energy Investment Conference in Denver, Colorado on August 18-19th, 2025. Amplify’s Chief Executive Officer, Dan Furbee, will be participating in one-on-one meetings with investors on Monday, August 18th and Tuesday, August 19th. In addition, Mr. Furbee will be presenting at 3:35 P.M. MT on Monday, August 18th ...

Core Insights - Inspired Entertainment, Inc. has launched V-Play Football Brazil in partnership with EstrelaBet, enhancing its presence in the Brazilian gaming market [1][2][3] - The product is designed to resonate with Brazilian football culture, offering high-frequency, ultra-realistic match simulations for a dynamic betting experience [2][4] - The integration is facilitated by Altenar, a sportsbook platform provider, showcasing a collaboration that combines technology and local market insights [3][5] Company Overview - Inspired Entertainment is a leading B2B provider of gaming content, technology, hardware, and services, operating in approximately 35 jurisdictions worldwide [5] - The company supplies gaming systems for around 50,000 gaming machines and offers virtual sports products through over 32,000 retail venues [5] - Inspired's portfolio includes digital games for more than 170 websites and various amusement entertainment solutions [5] EstrelaBet Overview - EstrelaBet is recognized as a leading Brazilian gamingtech company, operating under a definitive license in the national iGaming market [7][8] - The company has received multiple awards, including "Best Sports Betting Operator in Brazil" and "Best Responsible Gambling Initiative" [7][10] - EstrelaBet emphasizes innovation, responsible gaming, and community engagement, partnering with FUMEC University to develop initiatives for problem gambling prevention [8][9]

ATHENS, Greece, Aug. 12, 2025 (GLOBE NEWSWIRE) -- Okeanis Eco Tankers Corp. (“OET” or the “Company”) (NYSE: ECO / OSE: OET) announced today that the Company's board of directors (the “Board”) has declared a dividend on its common shares (the “Dividend”). Due to implementation of the Central Securities Depository Regulation (“CSDR”) in Norway, shareholders who hold common shares registered in Euronext Securities Oslo, the central securities depository in Norway (“VPS”) should please note the information on t ...

Core Viewpoint - Gouverneur Bancorp, Inc. has appointed Stephen M. Jefferies as the new President and Chief Executive Officer, effective September 2, 2025, succeeding Charles C. Van Vleet, Jr. who will retire on the same date [1][3]. Group 1: Leadership Transition - Stephen M. Jefferies brings nearly 40 years of banking experience and a proven track record of financial leadership to the role [2][3]. - Charles C. Van Vleet, Jr. will retire as Interim President and Chief Executive Officer on September 2, 2025, but plans to remain with the company until December 31, 2025, to assist with the transition [3][4]. Group 2: Company Overview - Gouverneur Bancorp, Inc. is the holding company for Gouverneur Savings and Loan Association, which was founded in 1892 and provides deposit and loan services [5]. - As of June 30, 2025, the company reported total assets of $196.7 million, total deposits of $159.4 million, and total stockholders' equity of $31.4 million [5].

SEOUL, South Korea, Aug. 12, 2025 (GLOBE NEWSWIRE) -- DoubleDown Interactive Co., Ltd. (NASDAQ: DDI) (“DoubleDown” or the “Company”), a leading developer and publisher of digital games on mobile and web-based platforms, today announced unaudited financial results for the second quarter ended June 30, 2025. Beginning with the fourth quarter of 2024, the Company is reporting its financial results in accordance with International Financial Reporting Standards (“IFRS”). As such, the financial results for the se ...

MARKHAM, Ontario, Aug. 12, 2025 (GLOBE NEWSWIRE) -- Sienna Senior Living Inc. (“Sienna” or the “Company”) (TSX: SIA) today announced its financial results for the three and six months ended June 30, 2025. Highlights Average Same Property Occupancy in retirement segment up 150 basis points (“bps”) year-over-year to 92.1% in Q2 2025 and further increased to 93.1% in July 2025Revenue, Proportionate Basis, excluding One-Time Items, increased by 17.4% to $253.6 million in Q2 2025Same Property Net Operating Incom ...

HOUSTON, Aug. 12, 2025 (GLOBE NEWSWIRE) -- Archrock, Inc. (NYSE:AROC) (“Archrock”) announced today the dual listing of its common stock on NYSE Texas, the newly launched fully electronic equities exchange headquartered in Dallas, Texas. “Our listing history with the New York Stock Exchange, through Archrock and its predecessor companies, began in 1997. We are pleased to join the NYSE Texas and support this pro-business initiative in the Lonestar State, which is home to our corporate headquarters and a major ...

Vancouver, BC, Aug. 12, 2025 (GLOBE NEWSWIRE) -- Oxley Bridge Acquisition Limited (Nasdaq: OBAWU) (the “Company”) announced today that, commencing August 15, 2025, holders of the units sold in the Company’s initial public offering may elect to separately trade the Company’s Class A ordinary shares and warrants included in the units. No fractional warrants will be issued upon separation of the units and only whole warrants will trade. The Class A ordinary shares and warrants that are separated will trade on ...

• First study participant randomized in Phase 3 CATT1 trial evaluating cadisegliatin for the treatment of type 1 diabetes with data expected in second half of 2026 • Cadisegliatin intellectual property portfolio expanded • Leadership team strengthened HIGH POINT, N.C., Aug. 12, 2025 (GLOBE NEWSWIRE) -- vTv Therapeutics Inc. (Nasdaq: VTVT), a late-stage biopharmaceutical company focused on the development of cadisegliatin, a potential first-in-class oral adjunctive therapy to insulin being investigated for t ...